Cargando…
TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities
Compared to other breast cancers, triple-negative breast cancer (TNBC) usually affects younger patients, is larger in size, of higher grade and is biologically more aggressive. To date, conventional cytotoxic chemotherapy remains the only available treatment for TNBC because it lacks expression of t...
Autores principales: | Camorani, Simona, Fedele, Monica, Zannetti, Antonella, Cerchia, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316260/ https://www.ncbi.nlm.nih.gov/pubmed/30428522 http://dx.doi.org/10.3390/ph11040123 |
Ejemplares similares
-
Optimization of Short RNA Aptamers for TNBC Cell Targeting
por: Camorani, Simona, et al.
Publicado: (2022) -
Aptamer-Based Strategies to Boost Immunotherapy in TNBC
por: Agnello, Lisa, et al.
Publicado: (2023) -
Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers
por: Camorani, Simona, et al.
Publicado: (2017) -
Aptamers and antibodies: rivals or allies in cancer targeted therapy?
por: Agnello, Lisa, et al.
Publicado: (2021) -
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer
por: Camorani, Simona, et al.
Publicado: (2018)